Sinclair Pharmaceuticals Ltd
 

Decapinol

Home
Where to get Decapinol
About gingivitis and periodontitis
About Decapinol
Corporate site

 

 

About Decapinol™

Decapinol is registered in the EU and in the USA as a medical device.

How Decapinol works
Decapinol has a novel mode of action. It works at the interface between dental plaque bacteria and the surface of the teeth and gums. Decapinol reduces adherence of the bacterial plaque to the oral surfaces, and also of bacteria to each other1. This mode of action not only reduces the formation of new plaque but also breaks up existing plaque, making it easier to remove with normal toothbrushing. By reducing the presence of plaque, the amount of bacterial toxins released into the gum is reduced. The end result is a reduction in both plaque and gingivitis.

Decapinol’s efficacy and safety in the reduction of plaque and treatment of gingivitis has been demonstrated in extensive clinical studies carried out by leading periodontists.

Not an anti-bacterial agent
Decapinol’s mode of action is different from that of other therapeutic agents for dental plaque control and the treatment of gingivitis, which work by killing oral bacteria. Decapinol has low antimicrobial activity against the normal primary colonising oral flora. Decapinol provides an intelligent and desirable method of treating gingivitis, in which the ecological balance of oral flora is maintained, avoiding indiscriminate killing of all oral bacteria.

Lack of dark staining
Decapinol does not cause the semi-permanent dark tooth-staining that occurs with chlorhexidine, and which often restricts the duration of use of chlorhexidine products in the treatment and prevention of gingivitis. Chlorhexidine is the key ingredient of most anti-gingivitis products currently recommended by dentists.

Lack of interaction with toothpaste
The efficacy of Decapinol is not reduced by SLS, a common ingredient of toothpaste, unlike chlorhexidine2.

How to use Decapinol
Twice a day after normal toothbrushing, rinse the mouth with 10ml of Decapinol mouthwash for around 1 minute.

Decapinol - new and intelligent mode of action

1

Klinge B, Matsson L, Attstrom R et al. Effect of local application of delmopinol hydrochloride on developing and early established supragingival plaque in humans. J Clin Periodontol 1996; 23: 542-547

2 Barkvoll P, Rölla G, Svendsen AK. Interaction between chlorhexidine digluconate and sodium lauryl sulphate in vivo. J Clin Periodontol 1989; 16:593-595
 

If you have any questions about Decapinol, please email us on info@decapinol.com

Sinclair Pharmaceuticals: Borough Road, Godalming, Surrey, GU7 2AB, UK
Tel: +44 (0)1483 426 644
Fax: + 44 (0)1483 860 927

© Sinclair Pharmaceuticals Ltd. All rights reserved. Terms & Conditions. Privacy Policy.